Gilead Sciences has significantly expanded its footprint in the immunology and inflammatory bowel disease (IBD) therapeutic landscapes through a multi-billion-dollar…
Read More
Teva Pharmaceutical Industries Secures FDA Approval for Weltruza, a Once-Monthly Injectable Olanzapine to Transform Schizophrenia Care
The landscape of neuropsychiatric care has reached a significant milestone following the United States Food and Drug Administration (FDA) approval…
Read More
Roche Secures FDA Approval for Tecentriq in Stage III dMMR Colon Cancer Setting to Establish New Treatment Paradigm
The pharmaceutical landscape for gastrointestinal oncology has undergone a significant transformation following a landmark regulatory decision by the US Food…
Read More
Varda Space Industries Secures $251m in Series D Funding to Pioneer Commercial In-Space Pharmaceutical Manufacturing
Varda Space Industries has successfully closed a massive $251m Series D financing round, bringing its cumulative venture backing to $598m…
Read More
Novartis Secures Strategic Partnership with Abogen to Advance Novel T-Cell Engager Therapies in Autoimmune Disease
The landscape of pharmaceutical partnerships continues to evolve at a rapid pace, marked by strategic alliances designed to tackle complex…
Read More
Tolerance Bio Secures Exclusive Global Rights Outside Japan for Tanabe Pharma Anti-IL-33 Monoclonal Antibody TLB-33 in Landmark $560m Deal
Tolerance Bio has finalized a high-stakes licensing agreement with Tanabe Pharma, acquiring exclusive worldwide commercialization rights—excluding Japan—for TLB-33, a clinical-stage…
Read More
Novo Nordisk Secures $1.33bn Nanexa Licensing Deal to Accelerate Long-Acting Cardiometabolic Therapies
The global pharmaceutical landscape is undergoing a profound structural evolution, driven by surging demand for treatments addressing obesity, type 2…
Read More
Enveda Biosciences Secures $311m in Series E Funding to Accelerate AI-Powered Natural Drug Discovery Pipeline
Colorado-based biotechnology pioneer Enveda Biosciences has officially closed a substantial $311m Series E financing round, bringing its cumulative venture backing…
Read More
Nature-Inspired Biotechnology Project Secures $3.3 Million NSF Grant to Extract Critical Minerals and Silicon from Industrial Waste Streams
The global transition toward clean-energy technologies, advanced electronics, and electric mobility relies heavily on an uninterrupted supply of critical minerals…
Read More
Novo Secures $1.4bn Partnership With Orbis Medicines to Bolster Cardiometabolic Pipeline Through AI-Driven Macrocycle Therapeutics
In a strategic move to fortify its cardiovascular and metabolic disease pipeline following a sequence of high-profile clinical and commercial…
Read MoreYOU MAY HAVE MISSED
